Cytokine gene polymorphisms in obstructive sleep apnoea/hypopnoea syndrome

Sleep Medicine

Volumn 16, Issue 6, 2015, Pages 792-795

  Bielicki, P ^a   MacLeod, A K ^b   Douglas, N J ^c   Riha, R L ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cytokine gene polymorphisms; Interleukin 6; Interleukin 8; Lymphotoxin; Sleep apnoea; TNF alpha haplotypes

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; INTERLEUKIN 6 GENE; INTERLEUKIN 8 GENE; INTRON; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDERED BREATHING; TUMOR NECROSIS FACTOR ALPHA GENE; ALLELE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; ALLELES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938977397     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2015.01.006     Document Type: Article

References (20)

1. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003, 290:1906.
2. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85:1151-1158.
3. Entzian P., Linnemann K., Schlaak M., et al. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996, 153:1080-1086.
4. Mills P.J., Dimsdale J.E. Sleep apnea: a model for studying cytokines, sleep, and sleep disruption. Brain Behav Immun 2004, 18:298-303.
5. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
6. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005, 112:2660-2667.
7. Ryan S., Taylor C.T., McNicholas W.T. Predictors of elevated nuclear factor-{kappa}B-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006, 174:824-830.
8. Riha R.L., Brander P., Vennelle M., et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005, 26:673-678.
9. Bhushan B., Guleria R., Misra A., et al. TNF-alpha gene polymorphisms and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med 2009, 103:386-392.
10. Ruuls S.R., Sedgwick J.D. Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models. Am J Hum Genet 1999, 65:294-301.
11. Burioka N., Miyata M., Fukuoka Y., et al. Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP). Chronobiol Int 2008, 25(5):827-834.
12. Cheshire K., Engleman H., Deary I., et al. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med 1992, 152:538-541.
13. Rechtschaffen A., Kales S. A manual of standardised terminology, techniques and scoring system for sleep stages of human subjects 1968, National Institutes of Health, Bethesda, MD.
14. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
15. Laird N., Horvath S., Xu X. Implementing a unified approach to family based tests of association. Genet Epidemiol 2000, 19:531-544.
16. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
17. Skoog T., van't Hooft F.M., Kallin B., et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999, 8:1443-1449.
18. Smith A.J., Humphries S.E. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009, 20(1):43-59.
19. Huth C., Illig T., Herder C., et al. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulation glucose levels, interleukin-6 levels, and body mass index. Ann Med 2009, 41(2):128-138.
20. Hacking D., Knight J.C., Rockett K., et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004, 5(4):274-282.